SDC1 and Miyoshi myopathy: MM-EVs have been proven to directly act on ECs to affect angiogenesis, proliferation, and metastasis, which is associated with multiple cargos, like CD138 [18], proangiogenic factors [19,20], miR-135b [21], and piRNA-823 [22].